Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{ba2a0adeda994d37a15068b017aa5064,
title = "Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours",
author = "Ulrik Lassen",
year = "2020",
month = "2",
doi = "10.1016/S1470-2045(19)30789-2",
language = "English",
volume = "21",
pages = "193--194",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "The/Lancet Publishing Group",
number = "2",

}

RIS

TY - JOUR

T1 - Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

AU - Lassen, Ulrik

PY - 2020/2

Y1 - 2020/2

U2 - 10.1016/S1470-2045(19)30789-2

DO - 10.1016/S1470-2045(19)30789-2

M3 - Comment/debate

VL - 21

SP - 193

EP - 194

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 2

ER -

ID: 59523149